In a rare move, the FDA last week posted photographs of dilapidated buildings as part of a warning letter for a Daman, India-based drug manufacturing facility.
The photographs are the latest sign that FDA Commissioner ...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.